Readers Forum Indian Pediatrics 2005; 42:1006 |
Reply |
It should be clearly understood that in US DTwP is not used in infant and adolescent immunization either in monovalent or combination formulation. In India all the Hib conjugate combination vaccine formulation are containing only DTwP. The efficacy and immune response of Hib component in the DTwP-Hib combination formulation have not been questioned and many other developing countries also recommend their use either in monovalent or combination formulation. Hence in India IAP also recommends the use of DTwP-Hib combination formulation as well as DTwP-HB-Hib combination formulation wherever indicated. A. Parthasarathy, |